Cancer Medicine That Fights Parkinson’s

Tuesday, October 20, 2015

Cancer Medicine for Parkinson’s

A small clinical trial conducted by researchers from the Georgetown University Medical Center has found that cancer drug could be an effective answer to treat Parkinson’s disease. The research involved administering nilotinib; a drug used to treat patients with certain type of leukaemia, to 12 patients suffering from Parkinson’s disease and ‘dementia with Lewy bodies’, for six months.

To everyone’s amazement these patients experienced improved cognition, motor and non-motor skills. The remarkable part of the experiment was that the drug was tried on patients with advanced stages of the disease. After the experiment, three patients who could not speak were able to hold conversations. Similarly, another patient was able to walk after being confined to a wheelchair.

Nilotinib works by clearing out proteins that accumulate in the brain cells of people suffering from Parkinson’s disease. However, doctors cautioned against the use of this drug as there was no involvement of a control group. 

The most wonderful and precious element of universe is the human life which can only be guided by the right knowledge and right attitude. So, here is an ocean of knowledge, both in English and Hindi encompassing every detail and each facet of human life which ‘one must know’ in order to grow and attain the summits of success. A team of around 200 dedicated members is working ceaselessly to turn such a colossal dream into reality. We are confident that this portal will help bring change in people across the world.

Content creation, research, development and execution done in-house at Aatman Innovations.